Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2137435rdf:typepubmed:Citationlld:pubmed
pubmed-article:2137435lifeskim:mentionsumls-concept:C0035237lld:lifeskim
pubmed-article:2137435lifeskim:mentionsumls-concept:C2349001lld:lifeskim
pubmed-article:2137435lifeskim:mentionsumls-concept:C0681850lld:lifeskim
pubmed-article:2137435lifeskim:mentionsumls-concept:C1706203lld:lifeskim
pubmed-article:2137435lifeskim:mentionsumls-concept:C2697811lld:lifeskim
pubmed-article:2137435lifeskim:mentionsumls-concept:C0004048lld:lifeskim
pubmed-article:2137435lifeskim:mentionsumls-concept:C0178602lld:lifeskim
pubmed-article:2137435lifeskim:mentionsumls-concept:C0205307lld:lifeskim
pubmed-article:2137435lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:2137435lifeskim:mentionsumls-concept:C0700580lld:lifeskim
pubmed-article:2137435lifeskim:mentionsumls-concept:C0348084lld:lifeskim
pubmed-article:2137435lifeskim:mentionsumls-concept:C1550501lld:lifeskim
pubmed-article:2137435pubmed:issue1lld:pubmed
pubmed-article:2137435pubmed:dateCreated1990-3-27lld:pubmed
pubmed-article:2137435pubmed:abstractTextThe influence of cholinergic receptor blockade on the impedance of the respiratory system was studied in 10 healthy volunteers in a frequency spectrum between 4 and 52 Hz by means of the forced pseudo random-noise oscillation technique. Ipratropium bromide was used in the inhaled form in two doses (0.040 and 0.200 mg). Both does caused a significant decrease in oscillatory airway resistance, Rrs. No dose effect on Rrs was found. Both doses caused an increase in the reactance of the respiratory system, Xrs. This increase in Xrs was significantly greater after the inhalation of the higher dose. The effect of both doses on the real part of impedance can be explained by a dilation of the central airways. Furthermore, inhaled ipratropium bromide, especially in the higher dose, led to an increase in the imaginary part of impedance suggesting a decrease in the capacitance of pulmonary structures in normal subjects.lld:pubmed
pubmed-article:2137435pubmed:languageenglld:pubmed
pubmed-article:2137435pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2137435pubmed:citationSubsetIMlld:pubmed
pubmed-article:2137435pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2137435pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2137435pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2137435pubmed:statusMEDLINElld:pubmed
pubmed-article:2137435pubmed:monthJanlld:pubmed
pubmed-article:2137435pubmed:issn0174-4879lld:pubmed
pubmed-article:2137435pubmed:authorpubmed-author:WoutersE FEFlld:pubmed
pubmed-article:2137435pubmed:authorpubmed-author:WesselingG...lld:pubmed
pubmed-article:2137435pubmed:authorpubmed-author:GreveL HLHlld:pubmed
pubmed-article:2137435pubmed:authorpubmed-author:VonkJ MJMlld:pubmed
pubmed-article:2137435pubmed:issnTypePrintlld:pubmed
pubmed-article:2137435pubmed:volume28lld:pubmed
pubmed-article:2137435pubmed:ownerNLMlld:pubmed
pubmed-article:2137435pubmed:authorsCompleteYlld:pubmed
pubmed-article:2137435pubmed:pagination33-8lld:pubmed
pubmed-article:2137435pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:2137435pubmed:meshHeadingpubmed-meshheading:2137435-...lld:pubmed
pubmed-article:2137435pubmed:meshHeadingpubmed-meshheading:2137435-...lld:pubmed
pubmed-article:2137435pubmed:meshHeadingpubmed-meshheading:2137435-...lld:pubmed
pubmed-article:2137435pubmed:meshHeadingpubmed-meshheading:2137435-...lld:pubmed
pubmed-article:2137435pubmed:meshHeadingpubmed-meshheading:2137435-...lld:pubmed
pubmed-article:2137435pubmed:meshHeadingpubmed-meshheading:2137435-...lld:pubmed
pubmed-article:2137435pubmed:meshHeadingpubmed-meshheading:2137435-...lld:pubmed
pubmed-article:2137435pubmed:meshHeadingpubmed-meshheading:2137435-...lld:pubmed
pubmed-article:2137435pubmed:meshHeadingpubmed-meshheading:2137435-...lld:pubmed
pubmed-article:2137435pubmed:meshHeadingpubmed-meshheading:2137435-...lld:pubmed
pubmed-article:2137435pubmed:meshHeadingpubmed-meshheading:2137435-...lld:pubmed
pubmed-article:2137435pubmed:meshHeadingpubmed-meshheading:2137435-...lld:pubmed
pubmed-article:2137435pubmed:meshHeadingpubmed-meshheading:2137435-...lld:pubmed
pubmed-article:2137435pubmed:year1990lld:pubmed
pubmed-article:2137435pubmed:articleTitleDose effects of inhaled ipratropium bromide on the impedance of the respiratory system in normal subjects.lld:pubmed
pubmed-article:2137435pubmed:affiliationDepartment of Pulmonary Diseases, State University Limburg, Maastricht, The Netherlands.lld:pubmed
pubmed-article:2137435pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2137435pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:2137435pubmed:publicationTypeControlled Clinical Triallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2137435lld:pubmed